Hemogenyx Pharmaceuticals PLC (HEMO) — Cash Flow Quality Index
Latest as of June 2016:
-2.34x
Hemogenyx Pharmaceuticals PLC (HEMO) has a Cash Flow Quality Index of -2.34x as of June 2016. Operating cash flow of GBX-164.90K is below net income of GBX70.50K, suggesting accrual-heavy earnings not yet converted to cash. Also explore Hemogenyx Pharmaceuticals PLC balance sheet assets for the complete picture of this company's asset base.
Cash Flow Quality Index
-2.34x
Operating CF / Net Income
Operating Cash Flow
GBX-164.90K
GBX
Net Income
GBX70.50K
GBX
Data as of
Jun 2016
Most recent filing
Annual Cash Flow Quality Index for Hemogenyx Pharmaceuticals PLC (None–None)
Year-by-year earnings quality comparison for Hemogenyx Pharmaceuticals PLC. For live market cap and the full company financial profile, see Hemogenyx Pharmaceuticals PLC (HEMO) market capitalisation.
| Year | Quality Index | Operating CF (GBX) | Net Income | YoY Change |
|---|
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.